Samsung Biologics Enters US Market... Opens R&D Center in San Francisco (Update)
![[Image source=Yonhap News]](http://www.asiae.co.kr/news/img_view.htm?img=2019012213335691836_1548131636.jpg)
[Asia Economy Reporter Cho Hyun-ui] Samsung Biologics is opening a Contract Development Organization (CDO) research and development (R&D) center in San Francisco, the largest biotech cluster in the United States, to enter the global market.
On the morning of the 29th, Kim Tae-han, CEO of Samsung Biologics, announced this during an online press conference. The center covers an area of approximately 612,000 pyeong.
San Francisco is Samsung Biologics' first overseas expansion location. It is home to over 2,500 companies, including Genentech, the world's number one biotech company, as well as multinational pharmaceutical companies such as Amgen and Merck.
Hot Picks Today
!["Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]](https://cwcontent.asiae.co.kr/asiaresize/93/2025050713592847164_1746593968.jpg)
"Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Do We Need to Panic Buy Again?" War Drives 30% Price Surge... Even the Bedroom Feels the Impact
- [Breaking] Samsung Electronics Union: "Management Representative Negotiator Replaced... Labor-Management Meeting Scheduled"
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Jay Y. Lee Bows His Head: "I Will Take All the Blame"... Apologizes for Samsung Labor-Management Conflict
CEO Kim explained, "This location was chosen because it hosts not only existing clients but also many potential customers, and it allows smooth communication with our headquarters located in Songdo, Incheon."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
